Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse

Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation

(2011) B. Brooks-Worrell et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Change you can B(cell)eive in: recent progress confirms a critical role for B cells in type 1 diabetes

(2011) Shannon K OʼNeill et al.   Current Opinion in Endocrinology Diabetes and Obesity

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

(2009) Mark D. Pescovitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autoimmune mechanisms in type 1 diabetes

(2008) Mikael Knip et al.   AUTOIMMUNITY REVIEWS

The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes

(2008) S. Oak et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies

(2007) Tyler R. Hall et al.   IMMUNOLOGY